Errihani H, Berrada N, El Bachiri M, Jouhadi H, et al. Observational study of trastuzumab biosimilar in patients with HER2-positive
breast cancer under routine clinical practice conditions in Morocco. BMC Cancer 2026 Apr 28. doi: 10.1186/s12885-026-16005.
PMID: 42050453
|